Observational studyMedicine2017

Does long-term efficacy differ between infliximab and adalimumab after 1 year of continuous administration?: A STROBE-compliant retrospective cohort study.

Haruka Otake et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.